Article Versions Notes

Saramago M, Costa VG, Souza CS, Bárria C, Domingues S, Viegas SC, Lousa D, Soares CM, Arraiano CM, Matos RG. The nsp15 Nuclease as a Good Target to Combat SARS-CoV-2: Mechanism of Action and Its Inactivation with FDA-Approved Drugs. Microorganisms. 2022; 10(2):342. https://doi.org/10.3390/microorganisms10020342

Saramago, Margarida, Vanessa G. Costa, Caio S. Souza, Cátia Bárria, Susana Domingues, Sandra C. Viegas, Diana Lousa, Cláudio M. Soares, Cecília M. Arraiano, and Rute G. Matos. 2022. "The nsp15 Nuclease as a Good Target to Combat SARS-CoV-2: Mechanism of Action and Its Inactivation with FDA-Approved Drugs" Microorganisms 10, no. 2: 342. https://doi.org/10.3390/microorganisms10020342

Saramago, M., Costa, V. G., Souza, C. S., Bárria, C., Domingues, S., Viegas, S. C., Lousa, D., Soares, C. M., Arraiano, C. M., & Matos, R. G. (2022). The nsp15 Nuclease as a Good Target to Combat SARS-CoV-2: Mechanism of Action and Its Inactivation with FDA-Approved Drugs. Microorganisms, 10(2), 342. https://doi.org/10.3390/microorganisms10020342